Clinical Trials for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Find clinical trials for transthyretin amyloidosis (attr) with cardiomyopathy. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

NCT ID: NCT06679946

This is an open‑label extension study testing vutrisiran in adults with transthyretin amyloidosis with cardiomyopathy (ATTR‑CM). The trial aims to learn more about long‑term safety and possible ben...

Enrolling by invitation

Phase: PHASE3 Type: interventional Locations: Dallas, Texas, United States, Houston, Texas, United States +70 more

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

NCT ID: NCT06128629

The MAGNITUDE trial is a Phase 3 study that is looking at a new treatment called NTLA-2001 for people with a condition called transthyretin amyloidosis with cardiomyopathy (ATTR-CM), which affects ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Chicago, Illinois, United States, Rochester, Minnesota, United States +135 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions